Prescription drug · NDA
Invokana (canagliflozin) NDC 50090-5029
Canagliflozin 300 mg/1 · Tablet, Film coated · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-5029-0 | 50090502900 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5029-0)Marketed from Apr 28, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Invokana
- Generic name (nonproprietary)
- canagliflozin
- Active ingredients
- Canagliflozin — 300 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 204042
- Marketing start
- Listing expires
- Other FDA classes
- P-Glycoprotein Inhibitors (Mechanism)Sodium-Glucose Transporter 2 Inhibitors (Mechanism)
- Identifiers
- Product ID 50090-5029_aa02f4ad-f077-4884-a644-f7df5537ce5dSPL ID aa02f4ad-f077-4884-a644-f7df5537ce5d
- Pharmacologic class
- Sodium-Glucose Cotransporter 2 Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090502900followed by a unit qualifier and the quantityPackage 50090-5029-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
Other NDCs under NDA 204042
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Invokanacanagliflozin | Canagliflozin 100 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-140 |
| Invokanacanagliflozin | Canagliflozin 300 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-141 |
| Invokanacanagliflozin | Canagliflozin 100 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | 55154-1425 |
| Invokanacanagliflozin | Canagliflozin 300 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | 55154-1426 |
| Invokanacanagliflozin | Canagliflozin 100 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-5034 |
| Invokanacanagliflozin | Canagliflozin 300 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-4364 |